Form 8-K - Current report:
SEC Accession No. 0001104659-23-042811
Filing Date
2023-04-06
Accepted
2023-04-06 17:27:01
Documents
12
Period of Report
2023-04-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2312057d1_8k.htm   iXBRL 8-K 23146
  Complete submission text file 0001104659-23-042811.txt   196545

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bzyr-20230406.xsd EX-101.SCH 3060
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bzyr-20230406_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bzyr-20230406_pre.xml EX-101.PRE 22613
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2312057d1_8k_htm.xml XML 3607
Mailing Address 9432 KATY FREEWAY HOUSTON TX 77055
Business Address 12000 RICHMOND AVE HOUSTON TX 77082 (713) 335-5697
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

EIN.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 8-K | Act: 34 | File No.: 000-23425 | Film No.: 23807226
SIC: 2835 In Vitro & In Vivo Diagnostic Substances